Metyrapone

美替拉酮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMetyrapone
Drug Alias NameMetyraponum甲双吡丙酮甲吡酮甲双丙吡酮Metopiron +[7] 
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo)
Mechanisms of ActionSteroid 11-beta-hydroxylase inhibitors
TargetsSteroid 11-beta-hydroxylase
Therapy Area/IndicationsDepressionCocaine-Related DisordersCushing Syndrome +[4] 
Global Approved IndicationsPituitary ACTH Hypersecretion
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1961/12/04
Country/TerritoryBelgiumUnited StatesPoland +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHra Pharma
China Registration ClassN/A

Develop Information

Active CompaniesEsteve Pharmaceuticals Sa
Inactive CompaniesHra PharmaNational Institute For Health Research, United KingdomNational Institute On Drug Abuse
Active IndicationsPituitary ACTH Hypersecretion
Inactive IndicationsDepressionCocaine-Related DisordersCushing Syndrome

Other Information

ATC CodeV04CD01
Related LinksWikipediaDrugBankKEGG